Strategy for the Development and Validation of Dissolution Tests for Solid Oral Dosage Forms

Pharmaceutical Technology

Volumn 20, Issue 5, 1996, Pages 58-72

  Skoug, J W ^a   Halstead, G W ^a   Theis, D L ^a   Freeman, J E ^a   Fagan, D T ^a   Rohrs, B R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0010514211     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. H.M. Abdou, Dissolution, Unavailability, and Bioequivalence (Mack Publishing Company, Hasten, PA, 1989).
2. A. Albert and E.P. Serjeant, The Determination of Ionization Constants (Chapman and Hall, New York, 3rd ed., 1984), pp. 14-64, 70-95. and 102-107.
3. W.J. Mader and L.T. Grady, "Determination of Solubility" in Physical Methods of Chemistry, A. Weissberger and B.W. Rossiter, Eds. (Wiley-Interscience, New York, 1971), Vol. 1, Part V. p. 259.
4. K.C. James, Solubility and Related Properties (Marcel Dekker, New York, 1986), pp. 36-59.
5. B.D. Anderson and R.A. Conradi, "Pitfalls in Solubility Measurement," presented at the Academy of Pharmaceutical Sciences Meeting, San Antonio, Texas, November 1980.
6. J.C. Sternberg, H.S. Stillo, and R.H. Schwendeman, "Spectrophotometric Analysis of Multicomponent Systems Using the Least-Squares Method in Matrix Form," Anal. Chem. 32, 84 (1960).
7. M.F. Merrick and H.L. Pardue, "Evaluation of Absorption and First- and Second-Derivative Spectra for Simultaneous Quantification of Bilirubin and Hemoglobin," Clin. Chem. 32, 598-602 (1986).
8. K.R. Beebe and B.R. Kowalski, "An Introduction to Multivariate Calibration and Analysis," Anal. Chem. 59, 1007A-1017A (1987).
9. D.M. Haaland and E.V. Thomas, "Partial Least-Squares Methods for Spectral Analyses. I. Relation to Other Quantitative Calibration Methods and the Extraction of Qualitative Information," Anal. Chem. 60, 1193-1202 (1988).
10. Automated Dissolution Testing Software, Hewlett-Packard.
11. A.C. Figazzotto and J.G. White, "Short Column Chromatography for a Robotic Dissolution Assay of Adinazolam Mesylate Tablets," Drug Dev. Ind. Pharm. 14(13), 1799-1807 (1988).
12. A. Mitsana-Papazoglou et al., "Dissolution Studies of Drug Formulations Using Ion-Selective Electrodes as Sensors in Air-Segmented Continuous Flow Analyzer," J. Pharm. Sci. 76, 724-730 (1987).
13. S.T. Chen, R.C. Thompson, and R.I. Poust, "Measurement of Pseudoephedrine Hydrochloride Dissolution Using Chloride-Ion Electrode," J. Pharm. Sci. 70, 1288-1289 (1981).
14. W.J. Dixon and F.J. Massey, Introduction to Statistical Analysis (McGraw-Hill, New York, 4th ed., 1983).
15. Y. Boer et al., "Guidelines for Dissolution Testing of Solid Oral Products," Pharm. Ind. 43, 334-343 (1981).
16. W.A. Hanson, Handbook of Dissolution Testing (Aster Publishing, Springfield, OR, 1982), pp. 27-43 and 91-113.
17. "Evaluation of Alternative Dissolution Apparatus," Pharm. Forum (March/April 1989), pp. 4984-4992.
18. B. Esbelin et al., "A New Method of Dissolution In Vitro, the 'Bio-Dis' Apparatus: Comparison with the Rotating Bottle Method and In Vitro/In Vivo Correlations," J. Pharm. Sci. 80 (10), 991-994 (1991).
19. S. Ian Borst, "Comparative pH-Gradient Dissolution of Several Oral Dosage Forms of Iron," Drug Dev. Ind. Pharm 17 (17), 2333-2339 (1991).
20. P.P. Sanghir et al., "Comparison of Three Dissolution Devices for Evaluating Drug Release," Drug Dev. Ind. Pharm. 20 (6), 961-980 (1994).
21. B.R. Rohrs et al., "USP Dissolution Apparatus 3 (Reciprocating Cell): Instrument Parameter Effects on Drug Release from Sustained-Release Formulations," J. Pharm. Sci. 84 (8), 922-926 (1995).
22. F. Langenbucher and H. Rettig, "Dissolution Rate Testing with the Column Method," Drug Dev. Ind. Pharm. 3 (3), 241-263 (1977).
23. B. Wennergren et al., "A Collaborative In Vitro Dissolution Study: Comparing the Flow-Through Method with the USP Paddle Method Using USP Prednisone Calibrator Tablets," Int. J. Pharm. 53, 35-41 (1989).
24. M. Nicklasson and F. Langenbucher, "Description and Evaluation of the Flow Cell Dissolution Apparatus as an Alternative Method for Drug Release," Pharm. Forum (May-June 1990), 532-540.
25. G.H. Zhang et al., "Evaluation of the Flow-Through Cell Dissolution Apparatus: Effects of Flow Rate, Glass Beads, and Tablet Position on Drug Release from Different Types of Tablets," Drug Dev. Ind. Pharm. 20 (13), 2063-2078 (1994).
26. J.H. De Smidt, J.C.A. Offringa, and D.J.A. Crommelin, "Dissolution Kinetics of Griseofulvin in Sodium Dodecylsulfate Solutions," J. Pharm. Sci. 76, 711 (1987).
27. V.P. Shah et al., "In Vitro Dissolution Profile of Water-Insoluble Drug Dosage Forms in the Presence of Surfactants," Pharm. Res. 6, 612-618 (1989).
28. J.P. Skelly and W.H. Barr, "Regulatory Assessment," in Controlled Drug Delivery: Fundamentals and Applications, J.R. Robinson and V.H. Lee, Eds. (Marcel Dekker, New York, 2nd ed., 1987), Chapter 7.
29. J.P. Skelly et al., "In Vitro Topographical Characterization as a Predictor of In Vivo Controlled Release Quinidine Gluconate Bioavailability," Drug Dev. Ind. Pharm. 12, 1177 (1986).
30. J.P. Skelly et al., "Topographical Dissolution Characterization for Controlled Release Products - A New Technique," Drug Dev. Ind. Pharm. 12, 1159 (1986).
31. C.F. Dick, R.A. Klassen, and G.E. Amidon, "Determination of the Sensitivity of a Tablet Formulation to Variations in Excipient Levels and Processing Conditions Using Optimization Techniques," Int. J. Pharm. 38, 23-31 (1987).
32. R.M. Franz et al., "In-Vitro Evaluation of a Mixed Polymeric Sustained-Release Matrix Using Response Surface Methodology," J. Controlled Release 5, 159-172 (1987).
33. J.B. Schwartz, J.R. Flamholz, and R.H. Press, "Computer Optimization of Pharmaceutical Formulations I: General Procedure," J. Pharm. Sci. 62, 1163-1170 (1973).
34. C.A. Burtis et al., "Optimization of a Kinetic Method by Response Surface Methodology and Centrifugal Analysis and Application to the Enzymatic Measurement of Ethanol," Anal. Chem. 53, 1154-1159 (1981).
35. Pharmaceutical Manufacturers Association, Quality Control Section, "Current Concepts for the Validation of Compendial Assays," Pharm. Forum 12 (2), 1241-1245 (1986).
36. D.C. Cox et al., "Guidelines for Dissolution Testing," Pharm. Technol. 2, 41-53 (1978).
37. B.R. Rohrs and D.J. Stelzer, "Deaeration Techniques for Dissolution Media," Dissolution Technologies 2 (2), Spring 1995.
38. "In Vitro/In Vivo Correlation for Extended-release Oral Dosage Forms," Pharm. Forum July/August (1988), pp. 4160-4161.
39. V.W. Steinijans et al., "A Novel Approach to the Specification of In Vitro Dissolution Boundaries Based on Regulatory Requirements for Bioequivalence,"Arzneim.-Forsch./Drug Res. 38, 1238-1241 (1988).
40. J.P. Skelly, "Bioavailability of Sustained-Release Dosage Forms - Relationship with In Vitro Dissolution" in Oral Sustained Release Formulations: Design and Evaluation, A. Yacobi and E. Halperin-Walega, Eds. (Pergamon Press, New York, 1988), Chapter 3.
41. J.P. Skelly et al., "Report of the Workshop on Controlled-Release Dosage Forms: Issues and Controversies," Pharm. Res. 4, 75-77 (1987).
42. J.P. Skelly et al., "In Vitro and In Vivo Testing and Correlation for Oral Controlled/Modified Release Dosage Forms," Pharm. Res. 7 (9), 975-982 (1990).
43. J.E. Freeman, E.J. Antal, and R.E. Gordon, "Drug Release and Bioavailability Issues for Product Development: Industry Perspective," HPB/FDA/USP International Open Conference on Dissolution, Bioavailability, and Bioequivalence, June 1992.
44. J.P. Skelly et al., "Scale-Up of Oral Extended-Release Dosage Forms," Pharm. Res. 10, 1800-1805 (1993).
45. J.P. Skelly et al., "Scale-Up of Immediate-Release Oral Solid Dosage Forms," Pharm. Res. 10, 313-316 (1993).
46. G.L. Amidon et al., "A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of In Vitro Drug Product Dissolution and In Vivo Bioavailability," Pharm. Res. 12, 413-420 (1995).
47. M. Siewert, "Perspectives of In Vitro Dissolution Tests in Establishing In Vivo/In Vitro Correlations," Eur. J. Drug Metab. and Pharmacokinetics 18, 7-18 (1993).
48. V.P. Shah and R.L. Williams, "In Vivo and In Vitro Correlations: Scientific and Regulatory Perspectives," in Generics Bioequivalence, A.J. Jackson, Ed. (CRC, Boca Raton, FL, 1994), Chapter 6.